Indirect meta-analytical comparison of azathioprine and of beta interferon effectiveness in all forms of multiple sclerosis pooled together
Authors:
- 1 December 2014
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 347 (1-2) , 408-410
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Established and novel disease‐modifying treatments in multiple sclerosisJournal of Internal Medicine, 2014
- Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysisCochrane Database of Systematic Reviews, 2013
- Direct Comparison of Azathioprine and beta Interferon Efficacy in Multiple Sclerosis (P01.200)Neurology, 2013
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple SclerosisNew England Journal of Medicine, 2012
- Comparison of interferon beta products and azathioprine in the treatment of relapsing-remitting multiple sclerosisJournal of Neurology, 2007
- New treatments and azathioprine in multiple sclerosisThe Lancet, 1997
- Overview of azathioprine treatment in multiple sclerosisThe Lancet, 1991